Search Results 541-550 of 17378 for bisphosphonates side effects

1. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... Any adverse event(s) related to Step 1 Induction ... NOTE: Bisphosphonates are considered to be ...

2. B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

   The purpose of this study is to assess the side effects and best dose of lenalidomide when given together with rituximab-ifosfamide-carboplatin-etoposide (R-ICE) ...

3. Phase III Study of DCVAC Added to Standard Chemotherapy for Men with Metastatic Castration Resistant Prostate Cancer - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... A minimum of 28 days beyond initiation of bisphosphonate or denosumab therapy ...

4. Antidepressants Archives - Mayo Clinic News Network

   aftermath of mania can have an enduring negative effect on the patient's quality of life, explains Dr. Frye, the study's senior author. Mark Frye, M.D.. Dr.

5. Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer who Completed Pre-operative Therapy - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... The purpose of this research study is to find out what effects, good ...

6. Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... NOTE: Bisphosphonates are considered to be supportive care rather than ...

7. Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain (REACT) - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

8. A Study to Test the Addition of berzosertib to Usual Radiation Treatment for Chemotherapy-Resistant Breast Cancer - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... Note: The effects ... bisphosphonates which are permitted without restriction even during protocol treatment.

9. Certain medicines. Erectile dysfunction is a possible side effect of some common medicines. These include blood pressure medicines, antidepressants, ...

10. A Study of Treatment with Docetaxel and Prednisone, with or without Vaccine Therapy, for Patients who have Metastatic Hormone-Resistant Prostate Cancer - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... Prior and/or concurrent treatment with bisphosphonates, however, is permitted ... Must have negative ...